Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
About this item
Full title
Author / Creator
Cannon, Christopher P , Bhatt, Deepak L , Oldgren, Jonas , Lip, Gregory Y.H , Ellis, Stephen G , Kimura, Takeshi , Maeng, Michael , Merkely, Bela , Zeymer, Uwe , Gropper, Savion , Nordaby, Matias , Kleine, Eva , Harper, Ruth , Manassie, Jenny , Januzzi, James L , ten Berg, Jurrien M , Steg, P. Gabriel , Hohnloser, Stefan H and RE-DUAL PCI Steering Committee and Investigators
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In this trial, dabigatran plus a P2Y
12
inhibitor was compared with warfarin plus a P2Y
12
inhibitor and aspirin after PCI in patients with atrial fibrillation. The risk of bleeding was lower with dabigatran therapy; prevention of thromboembolic events was similar with the two strategies.
Alternative Titles
Full title
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
Authors, Artists and Contributors
Author / Creator
Bhatt, Deepak L
Oldgren, Jonas
Lip, Gregory Y.H
Ellis, Stephen G
Kimura, Takeshi
Maeng, Michael
Merkely, Bela
Zeymer, Uwe
Gropper, Savion
Nordaby, Matias
Kleine, Eva
Harper, Ruth
Manassie, Jenny
Januzzi, James L
ten Berg, Jurrien M
Steg, P. Gabriel
Hohnloser, Stefan H
RE-DUAL PCI Steering Committee and Investigators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_DiVA_org_uu_340755
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_340755
Other Identifiers
ISSN
0028-4793,1533-4406
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1708454
